Clinical Trials Logo

Enteritis clinical trials

View clinical trials related to Enteritis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05214768 Active, not recruiting - Clinical trials for Eosinophilic Gastroenteritis

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis

Start date: March 4, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.

NCT ID: NCT03678545 Active, not recruiting - Clinical trials for Eosinophilic Gastroenteritis

Dupilumab in Eosinophilic Gastritis

Start date: May 15, 2021
Phase: Phase 2
Study type: Interventional

40 participants with Eosinophilic Gastritis 12-70 years of age will be randomly assigned with dupilumab or placebo subcutaneous injections every two weeks for a total of 12 weeks. Study subjects who complete the 12-week treatment phase, may continue into an open label extension study, where dupilumab will be administered every two weeks for a total of 24 weeks.

NCT ID: NCT01305109 Active, not recruiting - Clinical trials for Viral Gastroenteritis Due to Rotavirus

A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E

ROTAVAC
Start date: March 2011
Phase: Phase 3
Study type: Interventional

The trial is a phase III randomized, double-blind, placebo-controlled trial with the primary objective of evaluating the efficacy of three doses of ORV 116E, 10^5.0 FFU, against severe rotavirus gastroenteritis, in comparison with a placebo in India.